LAUNCHING THE NEXT GENERATION OF HA-BASED INJECTABLES
Share
We at Fidia Pharma, pioneers in the field of hyaluronic acid-based products, are pleased to announce the launch of our comprehensive Hyal-System portfolio. This innovative range of injectables utilizes the regenerative and biostimulating properties of high-purity hyaluronic acid and offers exceptional solutions specifically designed for professional use in aesthetic medicine.
Innovative technology and high purity
The Hyal-System portfolio is characterized by the use of high-purity, non-animal hyaluronic acid with carefully selected molecular weights. We use advanced, patented technologies developed in our internationally recognized R&D laboratories to ensure the highest product quality and performance. The entire manufacturing process is strictly controlled to ensure optimal purity, molecular weight fractions, gel structure and the absence of reaction by-products.
Comprehensive product range
Our Hyal-System portfolio includes various products tailored to different clinical needs:
- HYAL-SYSTEM 1.8% is a hydrator consisting of 1000 kDa hyaluronic acid with a concentration of 18 mg/ml. It uses HA M.S.T. (Molecular Sieving Technology®) and is mainly applied to the face. HYAL-SYSTEM 1.8% provides skin hydration and revitalization and comes in a pre-filled 1 ml syringe with two 30G 13 mm needles.
- HYAL-SYSTEM ACP is a biostimulator consisting of autocrosslinked hyaluronic acid with a molecular weight of 200 kDa and a concentration of 20 mg/ml. The HA A.C.P. (Auto-Crosslinked Polymer Technology®) enables it to be used on the face, décolleté and hypertrophic scars. HYAL-SYSTEM ACP promotes skin rejuvenation, improves turgor and elasticity and treats hypertrophic scars. It is supplied in a pre-filled 1 ml syringe with a 30G 13 mm needle and a 30G 4 mm needle.
- HYAL-SYSTEM DUO is a dual injectable product consisting of 1.9% BDDE cross-linked hyaluronic acid and 0.6% ACP, with a concentration of 25 mg/ml. It utilizes Mu.C.H. (Multi-Crosslinked Hyaluronan Technology®) and can be applied to the entire face. HYAL-SYSTEM DUO provides long-term correction of skin defects, volume replenishment, skin rejuvenation, turgor and elasticity. It is supplied in a pre-filled 1 ml syringe with two 27G 13 mm needles.
- HYAL-SYSTEM VOL is a volumizing filler consisting of BDDE-crosslinked hyaluronic acid (1MDa+ 2MDa) with a concentration of 25 mg/ml. The Multi-Crosslinked Layering Hyaluronic Acid M.L.HA Technology™ enables application in facial areas that require volumetric augmentation. HYAL-SYSTEM VOL restores facial volume and contour and comes in a pre-filled 1 ml syringe with a 27G 13 mm needle and a 27G 19 mm needle.
- HYAL-SYSTEM LIP is a filler specially developed for the lips, consisting of BDDE-crosslinked hyaluronic acid with a concentration of 25 mg/ml. It uses M.L.HA (Multi-Crosslinked Layering Hyaluronic Acid Technology™), which enables the volume and contours of the lips to be corrected and restored. HYAL-SYSTEM LIP is supplied in a pre-filled 1 ml syringe with a 27G 19 mm needle and a 27G 13mm needle.
Technological superiority and clinical applications
The different molecular weights and patented technologies integrated in the Hyal-System portfolio ensure customized solutions for different aesthetic and therapeutic needs. Our products are designed for different injection depths, from the superficial and mid dermis to the deep dermis and hypodermis, offering professionals flexibility in treating specific skin conditions and cosmetic enhancements.
Global reach and regulatory compliance
Our extensive experience and commitment to quality is reflected in our global presence and compliance with strict international regulations. With over 60 years of research and development in hyaluronic acid, more than 1,100 patents and a presence in over 100 countries, we continue to set the standard in the industry. The Hyal System portfolio is manufactured in fully integrated facilities that control the entire supply chain from research to commercialization.